EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automated extracellular volume fraction measurement for diagnosis and prognostication in patients with light-chain cardiac amyloidosis

In-Chang Hwang iD, Eun Ju Chun, Pan Ki Kim, Myeongju Kim, Jiesuck Park, Hong-Mi Choi, Yeonyee E Yoon, Goo-Yeong Cho, Byoung Wook Choi

PLOS ONE · 22.01.2025 · 20 (1) · e0317741

DOI: 10.1371/journal.pone.0317741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 22.01.2025. Verfasst von In-Chang Hwang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, South Korea. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Cardiomyopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National IT Industry Promotion Agency, Seoul National University Bundang Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

T1 mapping on cardiac magnetic resonance (CMR) imaging is useful for diagnosis and prognostication in patients with light-chain cardiac amyloidosis (AL-CA). We conducted this study to evaluate the performance of T1 mapping parameters, derived from artificial intelligence (AI)-automated segmentation, for detection of cardiac amyloidosis (CA) in patients with left ventricular hypertrophy (LVH) and their prognostic values in patients with AL-CA. Methods and results A total of 300 consecutive patients who underwent CMR for differential diagnosis of LVH were analyzed. CA was confirmed in 50 patients (39 with AL-CA and 11 with transthyretin amyloidosis), hypertrophic cardiomyopathy in 198, hypertensive heart disease in 47, and Fabry disease in 5. A semi-automated deep learning algorithm (Myomics-Q) was used for the analysis of the CMR images. The optimal cutoff extracellular volume fraction (ECV) for the differentiation of CA from other etiologies was 33.6% (diagnostic accuracy 85.6%). The automated ECV measurement showed a significant prognostic value for a composite of cardiovascular death and heart failure hospitalization in patients with AL-CA (revised Mayo stage III or IV) (adjusted hazard ratio 4.247 for ECV ≥ 40%, 95% confidence interval 1.215–14.851, p-value = 0.024). Incorporation of automated ECV measurement into the revised Mayo staging system resulted in better risk stratification (integrated discrimination index 27.9%, p = 0.013; categorical net reclassification index 13.8%, p = 0.007).

Conclusions

T1 mapping on CMR imaging, derived from AI-automated segmentation, not only allows for improved diagnosis of CA from other etiologies of LVH, but also provides significant prognostic value in patients with AL-CA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin Light-chain AmyloidosisCardiomyopathiesHumansMaleFemalePrognosisAgedMiddle AgedMagnetic Resonance ImagingHypertrophy, Left VentricularDeep LearningDiagnosis, Differential

Autor:innen und Institutionen

  • Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, South Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, South Korea.
  • Department of Radiology, Seoul National University College of Medicine, Seoul, South Korea.
  • Phantomics, Inc., Seoul, South Korea.
  • Center for Artificial Intelligence in Healthcare, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, South Korea.

ORCID-Profile: In-Chang Hwang

Förderung

  • National IT Industry Promotion Agency
  • Seoul National University Bundang Hospital

Zitieren

APA

Hwang, I. C., Chun, E. J., Kim, P. K., Kim, M., Park, J., Choi, H. M., Yoon, Y. E., Cho, G. Y., & Choi, B. W. (2025). Automated extracellular volume fraction measurement for diagnosis and prognostication in patients with light-chain cardiac amyloidosis. PLOS ONE, 20(1), e0317741. https://doi.org/10.1371/journal.pone.0317741

Vancouver

Hwang IC, Chun EJ, Kim PK, Kim M, Park J, Choi HM, et al. Automated extracellular volume fraction measurement for diagnosis and prognostication in patients with light-chain cardiac amyloidosis. PLOS ONE. 2025;20(1):e0317741. doi:10.1371/journal.pone.0317741

BibTeX
@article{Hwang2025,
  author = {Hwang, In-Chang and Chun, Eun Ju and Kim, Pan Ki and Kim, Myeongju and Park, Jiesuck and Choi, Hong-Mi and Yoon, Yeonyee E and Cho, Goo-Yeong and Choi, Byoung Wook},
  title = {Automated extracellular volume fraction measurement for diagnosis and prognostication in patients with light-chain cardiac amyloidosis},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {1},
  pages = {e0317741},
  doi = {10.1371/journal.pone.0317741}
}
Kostenlos starten →